Chronic pain can be debilitating and often interferes with everyday functions. It affects more than 100 million Americans and is the primary cause of disability among adults in the U.S.1
Treatment options commonly include prescription medications, but opioid overdoses are the number one cause of preventable death in the United States and physicians and patients are seeking alternatives.
HF10 is an exciting and innovative treatment approved by the FDA that provides substantial relief for patients suffering from the severe effects of chronic back and leg pain - without the risk of addiction and abuse. This advanced treatment is being adopted across the country and is currently available at Georgia Pain Management.
Unlike traditional spinal cord stimulation devices, which deliver low-frequency electrical pulses to mask chronic pain with sensations commonly perceived as tingling, prickling, pins-and-needles, or vibrating, called paresthesia (which many patients consider to be a nuisance) - Nevro's HF10 delivers pain relief without these sensations - a major improvement for patients.
Additionally, the FDA approval of HF10 came with a label of superiority over traditional spinal cord stimulation therapy. Two-year safety and effectiveness data from a randomized study of HF10 are published in Neurosurgery2. In addition, the company's SENZA-EU study showed remarkable reductions in opioid intake among patients implanted with HF10 with the average dose per patient decreased by nearly 70 percent3.
- Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Inst. of Medicine of the National Academies, 2011.
- Kapural L, et al. Comparison of 10-kHz High-Frequency and Traditional Low-Frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: 24-month Results from a Multicenter, Randomized, Controlled Pivotal Trial. Neurosurgery, 9/2016.
- Al-Kaisy A, Van Buyten J-P, Smet I, Palmisani S, Pang D, Smith T. Sustained effectiveness of 10 kHz high-frequency spinal cord stimulation for patients with chronic, low back pain: 24-month results of a prospective multicenter study. Pain Med. 2014;15:347-354.